Merck KGaA (OTCMKTS:MKGAF) Shares Down 5.3% - Time to Sell?

Key Points

• Merck KGaA's shares fell 5.3% during mid-day trading, closing at $126.18 after a previous close of $133.25.
• The trading volume for the day was significantly lower, with only 24 shares traded, a 98% decline from the average session volume of 1,055 shares.
• The company has a market cap of $17 billion and operates in segments including Life Science, Healthcare, and Electronics.

Merck KGaA (OTCMKTS:MKGAF - ) fell 5.3% during mid-day trading on Monday . The stock traded as low as $126.18 and last traded at $126.18. 24 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 1,055 shares. The stock had previously closed at $133.25.

Merck KGaA Stock Down 1.3%

The stock has a 50-day moving average of $130.57 and a 200-day moving average of $135.76. The firm has a market cap of $17.00 billion, a price-to-earnings ratio of 20.09 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.